INmune Bio (INMB) Financials: Revenue & Earnings
INMB$1.50-0.01 -0.99%
$41.77M
Market Cap
—
P/E
—
Forward P/E
—
Score
INmune Bio (INMB) Financials: Revenue & Earnings
INMB price $1.50 -0.01 -0.99%
- Ticker
- INMB
- Price
- $1.50
- Change
- -0.01 -0.99%
- Market cap ?
- $41.77M
- Beta ?
- 0.90
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
INMB fair value $15.68. Price $1.50. Price is 90% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 15.14K. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.24% (beta 0.9). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 27.75M. Net debt -23.72M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-10-29 | — | -0.15 | — | 1.88M |
| 2026-08-06 | -0.05 | -0.21 | — | 1.16M |
| 2026-05-07 | -0.20 | -0.24 | — | 1.11M |
| 2026-03-30 | -0.18 | -0.27 | — | -6.12K |
| 2025-10-30 | -0.24 | -0.31 | — | — |
| 2025-08-07 | -1.05 | -0.37 | — | 3.00K |
| 2025-05-08 | -0.43 | -0.43 | 50.00K | — |
| 2025-03-27 | -0.40 | -0.54 | — | — |
| 2024-10-31 | -0.60 | -0.49 | — | 333 |
| 2024-08-01 | -0.50 | -0.63 | — | 14.00K |
| 2024-05-09 | -0.61 | -0.53 | 14.00K | 30.00K |
| 2024-03-28 | -0.47 | -0.44 | 28.00K | 40.00K |
| 2023-11-01 | -0.48 | -0.39 | 43.00K | 40.00K |
| 2023-08-07 | -0.36 | -0.40 | 46.00K | 38.00K |
| 2023-05-03 | -0.36 | -0.02 | 38.00K | — |
| 2023-03-02 | -0.32 | -0.48 | 97.00K | — |
| 2022-11-02 | -0.43 | -0.59 | 98.00K | — |
| 2022-08-03 | -0.38 | -0.50 | 16.00K | — |
| 2022-05-05 | -0.39 | -0.60 | 163.00K | 226.67K |
| 2022-03-03 | -0.55 | -0.56 | 163.00K | — |
| 2021-11-03 | -0.55 | -0.43 | 14.00K | 970.00K |
| 2021-08-04 | -0.44 | -0.33 | — | — |
| 2021-05-05 | -0.32 | -0.28 | 4.00K | 3.26K |
| 2021-03-04 | -0.24 | -0.33 | 10.92K | — |
| 2020-11-05 | -0.36 | -0.17 | — | — |
| 2020-08-05 | -0.20 | -0.20 | — | — |
| 2020-05-14 | -0.19 | -0.21 | — | — |
| 2020-03-11 | -0.22 | -0.25 | — | — |
| 2019-11-08 | -0.28 | -0.20 | — | — |
| 2019-08-09 | -0.19 | -0.19 | — | — |
| 2019-05-15 | -0.20 | -0.19 | — | — |
| 2019-03-29 | -0.17 | — | — | — |
| 2018-09-30 | -0.14 | — | — | — |
| 2018-06-30 | -0.55 | — | — | — |
| 2018-03-31 | -0.25 | — | — | — |
| 2017-12-31 | -0.04 | — | — | — |
| 2017-09-30 | -0.03 | — | — | — |
| 2017-06-30 | -0.03 | — | — | — |
| 2017-03-31 | 0.01 | — | — | — |
| 2016-12-31 | -0.03 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-15 | Clark Ronnie Duane | Buy | 100.00K | $2.33 | 233.00K |
| 2026-09-15 | SAPIRSTEIN JAMES | Buy | 100.00K | $2.33 | 233.00K |
| 2026-09-08 | Clark Ronnie Duane | Other | 0 | — | — |
| 2026-09-08 | SAPIRSTEIN JAMES | Other | 0 | — | — |
| 2026-07-02 | Juda Scott | Buy | 14.80K | $1.40 | 20.72K |
| 2026-07-02 | Juda Scott | Sell | 14.80K | $1.40 | 20.72K |
| 2026-07-02 | Lowdell Mark William | Buy | 7.21K | $1.40 | 10.10K |
| 2026-07-02 | Lowdell Mark William | Sell | 7.21K | $1.40 | 10.10K |
| 2026-07-02 | Moss David J | Buy | 9.01K | $1.40 | 12.62K |
| 2026-07-02 | Moss David J | Sell | 9.01K | $1.40 | 12.62K |
| 2025-12-01 | Moss David J | Buy | 750.00K | $1.48 | 1.11M |
| 2025-12-01 | Lowdell Mark William | Buy | 600.00K | $1.48 | 888.00K |
| 2025-12-01 | Ellspermann Cory Randall | Buy | 300.00K | $1.48 | 444.00K |
| 2025-12-01 | Schroeder Timothy j | Buy | 150.00K | $1.48 | 222.00K |
| 2025-12-01 | Juda Scott | Buy | 150.00K | $1.48 | 222.00K |
| 2025-12-01 | Ganjei James Kelly | Buy | 150.00K | $1.48 | 222.00K |
| 2025-12-01 | ALLEN MARCIA | Buy | 150.00K | $1.48 | 222.00K |
| 2025-11-18 | Schroeder Timothy j | Buy | 108.00K | $1.50 | 162.00K |
| 2025-11-18 | Schroeder Timothy j | Buy | 35.00K | $1.50 | 52.50K |
| 2025-11-18 | Schroeder Timothy j | Buy | 32.50K | $1.50 | 48.75K |
| 2025-11-18 | Schroeder Timothy j | Buy | 19.02K | $1.50 | 28.54K |
| 2025-11-18 | Schroeder Timothy j | Buy | 15.97K | $1.50 | 23.96K |
| 2025-11-18 | Schroeder Timothy j | Buy | 12.50K | $1.50 | 18.75K |
| 2025-11-18 | Schroeder Timothy j | Sell | 108.00K | $7.80 | 842.40K |
| 2025-11-18 | Schroeder Timothy j | Sell | 35.00K | $7.92 | 277.20K |
| 2025-11-18 | Schroeder Timothy j | Sell | 12.50K | $9.92 | 124.00K |
| 2025-11-18 | Schroeder Timothy j | Sell | 32.50K | $5.05 | 164.12K |
| 2025-11-18 | Schroeder Timothy j | Sell | 15.97K | $24.82 | 396.50K |
| 2025-11-18 | Schroeder Timothy j | Sell | 19.02K | $17.49 | 332.75K |
| 2025-11-18 | Schroeder Timothy j | Sell | 108.00K | $3.91 | 422.28K |
| 2025-11-18 | Schroeder Timothy j | Sell | 35.00K | $9.74 | 340.90K |
| 2025-11-18 | Moss David J | Buy | 400.00K | $1.50 | 600.00K |
| 2025-11-18 | Moss David J | Buy | 275.00K | $1.50 | 412.50K |
| 2025-11-18 | Moss David J | Buy | 223.00K | $1.50 | 334.50K |
| 2025-11-18 | Moss David J | Buy | 160.00K | $1.50 | 240.00K |
| 2025-11-18 | Moss David J | Buy | 130.00K | $1.50 | 195.00K |
| 2025-11-18 | Moss David J | Buy | 70.66K | $1.50 | 105.99K |
| 2025-11-18 | Moss David J | Buy | 59.34K | $1.50 | 89.01K |
| 2025-11-18 | Moss David J | Sell | 275.00K | $3.91 | 1.08M |
| 2025-11-18 | Moss David J | Sell | 223.00K | $5.05 | 1.13M |
| 2025-11-18 | Moss David J | Sell | 59.34K | $24.82 | 1.47M |
| 2025-11-18 | Moss David J | Sell | 160.00K | $9.92 | 1.59M |
| 2025-11-18 | Moss David J | Sell | 130.00K | $7.92 | 1.03M |
| 2025-11-18 | Moss David J | Sell | 400.00K | $7.80 | 3.12M |
| 2025-11-18 | Moss David J | Sell | 70.66K | $17.49 | 1.24M |
| 2025-11-18 | Moss David J | Sell | 160.00K | $9.74 | 1.56M |
| 2025-11-18 | Lowdell Mark William | Buy | 400.00K | $1.50 | 600.00K |
| 2025-11-18 | Lowdell Mark William | Buy | 180.00K | $1.50 | 270.00K |
| 2025-11-18 | Lowdell Mark William | Buy | 140.00K | $1.50 | 210.00K |
| 2025-11-18 | Lowdell Mark William | Buy | 104.00K | $1.50 | 156.00K |
| 2025-11-18 | Lowdell Mark William | Buy | 100.00K | $1.50 | 150.00K |
| 2025-11-18 | Lowdell Mark William | Sell | 104.00K | $7.92 | 823.68K |
| 2025-11-18 | Lowdell Mark William | Sell | 180.00K | $3.91 | 703.80K |
| 2025-11-18 | Lowdell Mark William | Sell | 140.00K | $5.05 | 707.00K |
| 2025-11-18 | Lowdell Mark William | Sell | 400.00K | $7.80 | 3.12M |
| 2025-11-18 | Lowdell Mark William | Sell | 100.00K | $9.92 | 992.00K |
| 2025-11-18 | Juda Scott | Buy | 108.00K | $1.50 | 162.00K |
| 2025-11-18 | Juda Scott | Buy | 35.00K | $1.50 | 52.50K |
| 2025-11-18 | Juda Scott | Buy | 32.50K | $1.50 | 48.75K |
| 2025-11-18 | Juda Scott | Buy | 19.02K | $1.50 | 28.54K |
| 2025-11-18 | Juda Scott | Buy | 15.97K | $1.50 | 23.96K |
| 2025-11-18 | Juda Scott | Buy | 12.50K | $1.50 | 18.75K |
| 2025-11-18 | Juda Scott | Sell | 32.50K | $5.05 | 164.12K |
| 2025-11-18 | Juda Scott | Sell | 35.00K | $9.74 | 340.90K |
| 2025-11-18 | Juda Scott | Sell | 15.97K | $24.82 | 396.50K |
| 2025-11-18 | Juda Scott | Sell | 19.02K | $17.49 | 332.75K |
| 2025-11-18 | Juda Scott | Sell | 108.00K | $3.91 | 422.28K |
| 2025-11-18 | Juda Scott | Sell | 108.00K | $7.80 | 842.40K |
| 2025-11-18 | Juda Scott | Sell | 35.00K | $7.92 | 277.20K |
| 2025-11-18 | Juda Scott | Sell | 12.50K | $9.92 | 124.00K |
| 2025-11-18 | Ganjei James Kelly | Buy | 108.00K | $1.50 | 162.00K |
| 2025-11-18 | Ganjei James Kelly | Buy | 35.00K | $1.50 | 52.50K |
| 2025-11-18 | Ganjei James Kelly | Buy | 32.50K | $1.50 | 48.75K |
| 2025-11-18 | Ganjei James Kelly | Buy | 19.02K | $1.50 | 28.54K |
| 2025-11-18 | Ganjei James Kelly | Buy | 15.97K | $1.50 | 23.96K |
| 2025-11-18 | Ganjei James Kelly | Buy | 12.50K | $1.50 | 18.75K |
| 2025-11-18 | Ganjei James Kelly | Sell | 19.02K | $17.49 | 332.75K |
| 2025-11-18 | Ganjei James Kelly | Sell | 108.00K | $3.91 | 422.28K |
| 2025-11-18 | Ganjei James Kelly | Sell | 15.97K | $24.82 | 396.50K |
| 2025-11-18 | Ganjei James Kelly | Sell | 35.00K | $9.74 | 340.90K |
| 2025-11-18 | Ganjei James Kelly | Sell | 32.50K | $5.05 | 164.12K |
| 2025-11-18 | Ganjei James Kelly | Sell | 12.50K | $9.92 | 124.00K |
| 2025-11-18 | Ganjei James Kelly | Sell | 108.00K | $7.80 | 842.40K |
| 2025-11-18 | Ganjei James Kelly | Sell | 35.00K | $7.92 | 277.20K |
| 2025-11-18 | Ellspermann Cory Randall | Buy | 75.00K | $1.50 | 112.50K |
| 2025-11-18 | Ellspermann Cory Randall | Buy | 70.00K | $1.50 | 105.00K |
| 2025-11-18 | Ellspermann Cory Randall | Buy | 40.00K | $1.50 | 60.00K |
| 2025-11-18 | Ellspermann Cory Randall | Buy | 30.00K | $1.50 | 45.00K |
| 2025-11-18 | Ellspermann Cory Randall | Sell | 30.00K | $9.92 | 297.60K |
| 2025-11-18 | Ellspermann Cory Randall | Sell | 70.00K | $5.05 | 353.50K |
| 2025-11-18 | Ellspermann Cory Randall | Sell | 40.00K | $21.06 | 842.40K |
| 2025-11-18 | Ellspermann Cory Randall | Sell | 75.00K | $3.91 | 293.25K |
| 2025-11-18 | Ellspermann Cory Randall | Sell | 30.00K | $7.92 | 237.60K |
| 2025-11-18 | ALLEN MARCIA | Buy | 108.00K | $1.50 | 162.00K |
| 2025-11-18 | ALLEN MARCIA | Buy | 35.00K | $1.50 | 52.50K |
| 2025-11-18 | ALLEN MARCIA | Buy | 32.50K | $1.50 | 48.75K |
| 2025-11-18 | ALLEN MARCIA | Buy | 19.02K | $1.50 | 28.54K |
| 2025-11-18 | ALLEN MARCIA | Buy | 15.97K | $1.50 | 23.96K |
| 2025-11-18 | ALLEN MARCIA | Buy | 12.50K | $1.50 | 18.75K |
| 2025-11-18 | ALLEN MARCIA | Sell | 35.00K | $7.92 | 277.20K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 87, holders +1 vs prior quarter. Ownership 16.27%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 706.42K | 19.41K | +2.83% | 1.15M |
| AQR CAPITAL MANAGEMENT LLC | 662.22K | 391.90K | +144.98% | 1.08M |
| BLACKROCK, INC. | 311.61K | -882.50K | -73.90% | 507.93K |
| RAYMOND JAMES FINANCIAL INC | 213.00K | 9.75K | +4.80% | 347.18K |
| GEODE CAPITAL MANAGEMENT, LLC | 190.22K | -304.75K | -61.57% | 310.28K |
| GOLDMAN SACHS GROUP INC | 185.25K | -46.34K | -20.01% | 301.95K |
| MILLENNIUM MANAGEMENT LLC | 159.56K | 159.56K | New | 260.08K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 158.45K | 140.95K | +805.44% | 258.28K |
| CURATED WEALTH PARTNERS LLC | 255 | 255 | New | 238.54K |
| JANE STREET GROUP, LLC | 134.23K | 120.13K | +852.00% | 218.80K |
| UBS GROUP AG | 110.41K | -142.93K | -56.42% | 179.97K |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 108.30K | 0 | 0.00% | 176.53K |
| CITADEL ADVISORS LLC | 106.23K | 93.73K | +749.85% | 173.16K |
| VANGUARD FIDUCIARY TRUST CO | 104.78K | -18.41K | -14.94% | 170.78K |
| STATE STREET CORP | 93.36K | -197.52K | -67.90% | 152.18K |
| HRT FINANCIAL LP | 84.36K | 84.36K | New | 137.00K |
| IEQ CAPITAL, LLC | 82.39K | 57.82K | +235.40% | 134.29K |
| GSA CAPITAL PARTNERS LLP | 81.99K | 81.99K | New | 134.00K |
| VIRTU FINANCIAL LLC | 75.21K | 75.21K | New | 123.00K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 53.00K | 35.50K | +202.86% | 86.39K |
| LAIRD NORTON WETHERBY TRUST COMPANY, LLC | 52.00K | 2.00K | +4.00% | 84.76K |
| FOCUS ADVISOR SOLUTIONS, LLC | 43.56K | 531 | +1.23% | 71.00K |
| PNC FINANCIAL SERVICES GROUP, INC. | 42.64K | 2.52K | +6.28% | 69.50K |
| QUBE RESEARCH & TECHNOLOGIES LTD | 40.77K | 40.77K | New | 66.46K |
| MARINER, LLC | 40.32K | 21.28K | +111.73% | 65.72K |
Earnings and financials
INmune Bio, Inc. (INMB) trades at $1.50, with a market cap of $41.77M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn